Moderna Stock Gains on Better-Than-Expected Covid-19 Vaccine …

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

yahoo.com

Moderna Stock Gains On 2023 COVID Vaccine Sales (NASDAQ:MRNA)

2 weeks from now

Jan 8, 2024  · Moderna (MRNA) stock gains as it surpasses sales expectations for its COVID-19 vaccine, reporting $6.7B in sales for 2023. ... And 2023 revenues of $7bn way better than I …

seekingalpha.com

Moderna Stock Rises On Surprise Q3 Profit - Yahoo Finance

2 weeks from now

Nov 7, 2024  · Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit for the period amid its efforts to cut costs and $1.8 …

yahoo.com

Moderna’s New And Improved COVID Vaccine Produced Positive …

2 weeks from now

Moderna’s stock rose 1.1% in premarket trading, to put it on track for a fourth-straight gain. The company said that the mRNA-1283’s improved immunity response was importantly more acute …

msn.com

Moderna Surprises The Street By Predicting A Bigger-Than …

2 weeks from now

2 days ago  · Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna …

usnews.com

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

2 weeks from now

2 days ago  · Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending …

reuters.com

Moderna Stock Jumps 12%: Sell The News Or Buy The Future?

2 weeks from now

Jan 7, 2025  · Moderna stock jumped over 12% on concerns over the first confirmed death from bird flu in the United States. ... The spending on R&D was fueled by the outsized profits it …

marketbeat.com

Moderna's MRNA Technology Looks Undervalued Despite Lower …

2 weeks from now

1 day ago  · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …

morningstar.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024  · Moderna stock analysts model $321 million in sales of the company's vaccine this year. Mock notes Moderna's shot uses a pre-filled syringe, which could help it gain share from …

investors.com

Moderna's Covid Vaccine Obliterates Sales Expectations

2 weeks from now

Aug 3, 2022  · "As such, the Covid-19 vaccine tail wind is expected to continue." Moderna stock soared 16% to close at 186.49 on today's stock market. Moderna Stock: Sales Unexpected …

investors.com

Moderna Stock Gains On Raised COVID Vaccine Sales Outlook

2 weeks from now

Aug 3, 2023  · However, Moderna reported better-than-expected liquidity, indicating $3.8B in cash and equivalents at the end of the quarter compared to $3.2B at the end of 2022.

seekingalpha.com

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago  · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

Moderna Stock Has Lost 94% Of Its Value Over Four Years. Is It A …

2 weeks from now

1 day ago  · Moderna stock peaked at 497.49 in August 2021, at the height of the Covid pandemic. Since then, the stock has fallen precipitously, down 94% over the past four years. Is Moderna …

investors.com